Dificid Articles

IQWiG finds no added proven benefit for Astellas' fidaxomicin in Clostridium difficile infection

23 April 2013

Optimer Pharma to sell remaining stake in Optimer Biotech for $60 million

8 October 2012

Regulatory briefs: Amitiza in Japan; Dificid in Canada; Eurartesim roll-out

6 July 2012

Optimer Pharma could earn $90 million from new Astellas deal

30 March 2012

Astellas and Optimer’s C. difficile drug cleared in Europe

13 December 2011

More news from EMA/CHMP September meeting

26 September 2011

Optimer/Cubist’s Dificid poised to challenge Vancocin usage in C. difficile treatment; report

14 September 2011

US FDA approves Optimer’s Dificid for C. difficile infection

31 May 2011

Highlights from Digestive Disease Week

11 May 2011

US FDA advisory panel backs Optimer novel antibiotic Dificid for CDI

7 April 2011

Showing 1-10 of 10 articles

Go to beginningPrevious
  • 1
NextGo to end